San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
New Pharmacological Therapy Guidelines for HFrEF in 2021: Should You Start Treatment with ARNI? Can SGLT2 Inhibitors Eventually Become First Line Therapy?
Login to view comments.
Click here to Login
SESSION IV - Advances in Heart Failure Management